Covid-19: Wonder drugs become another weapon in ongoing battle against the virus
Recent tests by Merck of an antiviral pill that appears to cut hospitalisation risk by 50 per cent sent the company’s shares soaring. Other companies, including Dublin-based AiPharma, are also in the race to develop antiviral medications
This time last year, the race to produce a vaccine for Covid-19 was in full flow, with pharmaceutical companies competing to provide a “magic bullet” solution to the pandemic.
But away from the dazzling feats of science that ultimately proved successful, a quieter, but nonetheless important effort was taking place and is still ongoing: the quest to find an effective treatment for Covid-19.
They have varied from antibody infusions to off-label steroids, forays...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Freedom day postponed in favour of a step towards normality
The government will not phase out Nphet next month as it ‘proceeds with caution’
Government hopes to raise vaccination rates via passports for pubs and restaurants
Ministers hope that extending the use of vaccination passports beyond the planned date of October 22 will put pressure on more unvaccinated people to get the jab
The Last Post: Covid symptoms ‘drink-driving’ comparison is an analogy too far
Professor Philip Nolan of Nphet said ‘leaving your home with symptoms has to become socially unacceptable, like drink-driving’, but comparing people with allergies or head colds to people who drink and then get behind the wheel is over the top
Full vaccination more effective than a booster campaign, Nphet advisor says
Cathal Walsh says strain-specific top-ups can play a role but primary vaccination is still far more effective